Local commissioners and providers of healthcare have a responsibility to enable the guideline to be applied when individual professionals and people using services wish to use it. It is not mandatory to apply the recommendations, and the guideline does not override the responsibility to make decisions appropriate to the circumstances of the individual, in consultation with them and their families and carers or guardian.Īll problems (adverse events) related to a medicine or medical device used for treatment or in a procedure should be reported to the Medicines and Healthcare products Regulatory Agency using the Yellow Card Scheme. When exercising their judgement, professionals and practitioners are expected to take this guideline fully into account, alongside the individual needs, preferences and values of their patients or the people using their service. The recommendations in this guideline represent the view of NICE, arrived at after careful consideration of the evidence available. This guideline was previously called autism: recognition, referral, diagnosis and management of adults on the autism spectrum. For more information, see the surveillance decision. We will regularly review their potential impact on our autism guidelines. We are monitoring important initiatives in progress that may affect future service delivery.
June 2021: We have found no new evidence that affects the recommendations. Adults with autism and their families, partners and carers.Health and social care professionals (including those in the independent sector).assessment and interventions for families, partners and carers.interventions for coexisting mental disorders.interventions for behaviour that challenges.This guideline includes recommendations on: In June 2021, we amended the recommendations on identification and assessment to clarify that when the Autism-Spectrum Quotient – 10 items (AQ-10) is used to assess for possible autism, the score at which the person should be offered a comprehensive assessment is 6 or above. We have also produced guidelines on autism spectrum disorder in under 19s: recognition, referral and diagnosis and autism spectrum disorder in under 19s: support and management. It aims to improve access and engagement with interventions and services, and the experience of care, for people with autism. This guideline covers diagnosing and managing suspected or confirmed autism spectrum disorder (autism, Asperger’s syndrome and atypical autism) in people aged 18 and over.